Bill Text: US HB6400 | 2023-2024 | 118th Congress | Introduced
Bill Title: To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2023-11-17 - Referred to the Subcommittee on Health. [HB6400 Detail]
Download: US_Congress-2023-HB6400-Introduced.pdf